Product
Isolation of anti-Pseudomonas antibodies
1 clinical trial
2 indications
Indication
Pseudomonas aeruginosaIndication
Multi-antibiotic ResistanceClinical trial
Isolation of Human Recombinant Therapeutic Monoclonal Anti-Pseudomonas Antibodies From B Lymphocytes of Patients Who Have Been Followed for Infection or Colonization With Pseudomonas Aeruginosa: a Prospective Monocentric TrialStatus: Recruiting, Estimated PCD: 2025-10-01